SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-16-016060
Filing Date
2016-05-10
Accepted
2016-05-10 16:10:34
Documents
55
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sgyp-33116x10q.htm 10-Q 492928
2 EXHIBIT 31.1 sgyp-ex311x33116x10q.htm EX-31.1 11932
3 EXHIBIT 31.2 sgyp-ex312x33116x10q.htm EX-31.2 11955
4 EXHIBIT 32.1 sgyp-ex321x33116x10q.htm EX-32.1 6740
5 EXHIBIT 32.2 sgyp-ex322x33116x10q.htm EX-32.2 7403
  Complete submission text file 0001628280-16-016060.txt   3360152

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sgyp-20160331.xml EX-101.INS 574110
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgyp-20160331.xsd EX-101.SCH 31302
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sgyp-20160331_cal.xml EX-101.CAL 39772
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sgyp-20160331_def.xml EX-101.DEF 165982
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sgyp-20160331_lab.xml EX-101.LAB 419461
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgyp-20160331_pre.xml EX-101.PRE 260147
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

IRS No.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35268 | Film No.: 161635862
SIC: 2834 Pharmaceutical Preparations